Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells

Chin-Ho Kuo1, Yin-Che Lu, Ya-Shin Tseng

  • 1Division of Hematology-Oncology and Blood Bank, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.

Abstract

Insights

Reversine, a synthetic purine analogue, effectively suppresses human breast cancer cell growth by inducing cell cycle arrest, polyploidy, and apoptosis. This compound shows promise as a novel therapeutic agent for breast cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Reversine, a synthetic purine analogue, exhibits known tumor suppressive properties.
  • This study investigates reversine's specific antitumor effects on human breast cancer cell lines.

Purpose of the Study:

  • To evaluate reversine's efficacy in suppressing proliferation and inducing cell death in human breast cancer cells.
  • To elucidate the mechanisms underlying reversine's antitumor activity, including cell cycle regulation and apoptosis induction.

Main Methods:

  • Assessed cell viability, cell cycle progression, and apoptosis in MCF-7 and MDA-MB-231 cells following reversine treatment.
  • Analyzed key apoptosis markers such as PARP cleavage and caspase activation (caspase-3, -8, and -9).
  • Investigated the role of the caspase-dependent extrinsic pathway in reversine-induced apoptosis.

Main Results:

  • Reversine significantly reduced breast cancer cell viability in a dose-dependent manner.
  • Observed cell cycle arrest at the G2/M phase and induction of polyploidy in reversine-treated cells.
  • Demonstrated caspase-dependent apoptosis via the extrinsic pathway, evidenced by PARP cleavage and caspase-3/-8 activation, independent of caspase-9.

Conclusions:

  • Reversine inhibits human breast cancer cell growth through cell cycle arrest, polyploidy, and apoptosis induction.
  • The observed apoptosis is mediated by a mitochondria-independent pathway.
  • Reversine warrants further investigation as a potential therapeutic agent for breast cancer.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...